About Batavia Pharma
Batavia Pharma is a Healthcare company. It operates as a development, manufacturing, and commercialization of generic pharmaceuticals for global markets. Its Indian entity Batavia Pharma Private Limited reported revenue of ₹7.84 Cr. Batavia Pharma offers products and services including Generic Pharmaceuticals and R&D Services. Its focus areas include Pharmaceuticals, Generic Drugs, Development and Manufacturing and Research and Development.
Company details
Batavia Pharma was founded in 1985 and is recognized for its dedication to the development and manufacturing of high quality generics and value-added pharmaceutical products. A focus is placed on reducing unmet patient needs through consistent availability of medicines in Europe, the US, and other markets. Quality standards are upheld across operations, while innovation is fostered to address healthcare gaps. Consistency and dynamism are emphasized to ensure reliable delivery and adaptation to evolving needs, contributing to better global patient outcomes.
- SectorsHealthcare
- Email••••••••
- Social LinkedIn
- Legal Name Batavia Pharma Pvt. Ltd
- Date of Incorporation 04 Oct, 2016
- Jurisdiction Pune, Maharashtra, India
- Annual Revenue₹7.84 Cr
FY 2025 · +49% YoY
- Net Profit₹1.31 Cr
FY 2025 · 17% margin
- EBITDA₹2.19 Cr
FY 2025 · 28% margin
Associated legal entities of Batavia Pharma
Batavia Pharma operates through Batavia Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Batavia Pharma Private Limited CIN U24304PN2016PTC166674 | Active | 04 Oct 2016 | Pune, Maharashtra | ₹7.8 Cr | 20 | 4 | View details |
Products & Services of Batavia Pharma
Batavia Pharma offers a comprehensive portfolio of products and services, including Generic Pharmaceuticals and R&D Services.
Generic and value-added drugs are developed and manufactured to address patient needs in various markets
In-house research and development services are provided to innovate and create solutions for healthcare challenges
Board of directors of Batavia Pharma Private Limited (Batavia Pharma)
Batavia Pharma Private Limited is the primary company behind Batavia Pharma. The board of Batavia Pharma Private Limited currently have 4 directors; the longest-serving is Harish Nathalal Batavia, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harish Nathalal Batavia DIN 07612716 | Director | 04 Oct 2016 | 10 yrs | Batavia Pharma Private Limited |
| Tejas Harish Batavia DIN 07612680 | Director | 04 Oct 2016 | 10 yrs | Batavia Pharma Private Limited |
| Vishal Tinesh Batavia DIN 07612723 | Director | 04 Oct 2016 | 10 yrs | Batavia Pharma Private Limited |
| Tinesh Nathalal Batavia DIN 07612843 | Director | 04 Oct 2016 | 10 yrs | Batavia Pharma Private Limited |
Financials of Batavia Pharma
Figures of Batavia Pharma Private Limited, the primary company behind Batavia Pharma, for FY 2025. Revenue was ₹7.84 Cr (+49% year on year). Net profit was ₹1.31 Cr (17% margin). EBITDA was ₹2.19 Cr (28% margin). Revenue has grown at a compounded annual rate of +26% over three years and +23% over five years.
- ₹7.84 CrRevenue · FY 2025 · +49% YoY
- ₹1.31 CrNet profit · 17% margin
- ₹2.19 CrEBITDA · 28% margin
- ₹1 LakhPaid-up capital
- 20Employees (provident fund records)
- +26%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Batavia Pharma Private Limited are on its company page.
Detailed financial statements for Batavia Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Batavia Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Batavia Pharma
The primary company behind Batavia Pharma, Batavia Pharma Private Limited, reported revenue of ₹7.84 Cr for FY 2025, up 49% year on year.
Batavia Pharma was founded in 1985 and is recognized for its dedication to the development and manufacturing of high quality generics and value-added pharmaceutical products. A focus is placed on reducing unmet patient needs through consistent availability of medicines in Europe, the US, and other markets. Quality standards are upheld across operations, while innovation is fostered to address healthcare gaps. Consistency and dynamism are emphasized to ensure reliable delivery and adaptation to evolving needs, contributing to better global patient outcomes.
Batavia Pharma offers Generic Pharmaceuticals and R&D Services.
Batavia Pharma operates through Batavia Pharma Private Limited.
The legal entities of Batavia Pharma currently have 4 directors, including Harish Nathalal Batavia, Tejas Harish Batavia, Vishal Tinesh Batavia and others.